Bifogade filer
PDF
Kurs
-43,18%
Likviditet
0,44 MSEK
Kalender
| Est. tid* | ||
| 2025-11-27 | 11:00 | Kvartalsrapport 2025-Q3 |
| 2025-11-21 | N/A | Extra Bolagsstämma 2025 |
| 2025-08-28 | - | Kvartalsrapport 2025-Q2 |
| 2025-05-28 | - | Kvartalsrapport 2025-Q1 |
| 2025-05-09 | - | X-dag ordinarie utdelning POLAR 0.00 SEK |
| 2025-05-08 | - | Årsstämma |
| 2025-02-27 | - | Bokslutskommuniké 2024 |
| 2025-02-20 | - | Extra Bolagsstämma 2024 |
| 2024-12-05 | - | Split POLAR 300:1 |
| 2024-11-29 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-30 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-31 | - | Kvartalsrapport 2024-Q1 |
| 2024-05-29 | - | X-dag ordinarie utdelning POLAR 0.00 SEK |
| 2024-05-28 | - | Årsstämma |
| 2024-02-23 | - | Bokslutskommuniké 2023 |
| 2023-11-24 | - | Kvartalsrapport 2023-Q3 |
| 2023-09-08 | - | Extra Bolagsstämma 2023 |
| 2023-08-25 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-26 | - | Kvartalsrapport 2023-Q1 |
| 2023-05-17 | - | Årsstämma |
| 2023-05-05 | - | X-dag ordinarie utdelning POLAR 0.00 SEK |
| 2023-03-13 | - | Extra Bolagsstämma 2022 |
| 2023-02-24 | - | Bokslutskommuniké 2022 |
| 2022-11-25 | - | Kvartalsrapport 2022-Q3 |
| 2022-08-26 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-27 | - | Kvartalsrapport 2022-Q1 |
| 2022-05-06 | - | X-dag ordinarie utdelning POLAR 0.00 SEK |
| 2022-05-05 | - | Årsstämma |
| 2022-02-25 | - | Bokslutskommuniké 2021 |
| 2021-11-26 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-27 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-28 | - | Kvartalsrapport 2021-Q1 |
| 2021-05-06 | - | X-dag ordinarie utdelning POLAR 0.00 SEK |
| 2021-05-05 | - | Årsstämma |
| 2021-02-26 | - | Bokslutskommuniké 2020 |
| 2020-11-27 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-28 | - | Kvartalsrapport 2020-Q2 |
| 2020-07-01 | - | X-dag ordinarie utdelning POLAR 0.00 SEK |
| 2020-06-30 | - | Årsstämma |
| 2020-05-29 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-28 | - | Bokslutskommuniké 2019 |
| 2020-02-14 | - | Extra Bolagsstämma 2020 |
| 2019-10-23 | - | Kvartalsrapport 2019-Q3 |
| 2019-07-24 | - | Kvartalsrapport 2019-Q2 |
| 2019-05-07 | - | Split POLAR 16:1 |
| 2019-04-26 | - | Kvartalsrapport 2019-Q1 |
| 2019-03-19 | - | Årsstämma |
| 2019-02-04 | - | X-dag ordinarie utdelning POLAR 0.00 SEK |
| 2019-02-01 | - | Bokslutskommuniké 2018 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Spotlight |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Med-tech company PolarCool AB (publ.) continues to expand its presence in European ice hockey and has now signed its first agreement in Slovakia. The Slovak club HC Košice becomes the first team in the top-tier, Tipsport league, to include PolarCap® in its concussion management routines.
Slovakia has one of Central Europe's leading ice hockey leagues. With this establishment, PolarCool strengthens its presence within European ice hockey. The company is already active in several of Europe's top leagues, including Sweden, Finland, Germany, Austria, the United Kingdom, Switzerland, and the Czech Republic.
HC Košice's team doctor Michal Fečík comments:
-We look forward to offering our players acute treatment with PolarCap® in the event of a concussion. As the medical doctor of HC Košice, I see it as my obligation to provide my players with the best possible care. Including PolarCap®, a clinically evaluated treatment, was therefore an obvious choice.
PolarCool's CEO Erik Andersson comments:
-I am very pleased with HC Košice's commitment to player safety and that we have secured our first agreement for PolarCap® in Slovakia - a country with a strong ice hockey tradition. HC Košice is one of the country's leading clubs and will serve as an important ambassador for our technology in Slovakia. We look forward to the collaboration and expect more Slovak clubs to follow soon.
The two-year agreement with HC Košice represents a strategic breakthrough in the Slovak market. Although individual agreements may have limited financial impact, this marks an important step in PolarCool's long-term growth strategy and its ambition to strengthen its position in the European market.
For more information
Erik Andersson - CEO PolarCool AB (publ.)
+46 - 738 60 57 00
E-mail: erik.andersson@polarcool.se
About PolarCool AB (publ.)
PolarCool AB (publ.) is a Swedish medical technology company focused on developing and marketing products in the sports medicine field. Its primary product, PolarCap®, is designed to reduce the impact of concussion through targeted brain cooling. PolarCool works with professional teams across Europe in rugby, football, and ice hockey and it shares are listed on Spotlight Stock Market.